Thet Tun Aung, , , Mayandi Venktatesh, , , Mercy Halleluyah Periayah, , , Darren Shu Jeng Ting, , , Xiu Wang, , , Eunice Tze Leng Goh, , , Sai Bo Bo Tun, , , Candice Ho Ee Hua, , , Veluchamy Amutha Barathi, , , Navin Kumar Verma, , , Wang Yue, , , Donald Tiang Hwee Tan*, , , Anita Sook Yee Chan*, , and , Rajamani Lakshminarayanan*,
{"title":"Structure–Activity Relationship in ε-Lysine Peptides: The Length Effects on Antifungal Activity","authors":"Thet Tun Aung, , , Mayandi Venktatesh, , , Mercy Halleluyah Periayah, , , Darren Shu Jeng Ting, , , Xiu Wang, , , Eunice Tze Leng Goh, , , Sai Bo Bo Tun, , , Candice Ho Ee Hua, , , Veluchamy Amutha Barathi, , , Navin Kumar Verma, , , Wang Yue, , , Donald Tiang Hwee Tan*, , , Anita Sook Yee Chan*, , and , Rajamani Lakshminarayanan*, ","doi":"10.1021/acs.biomac.5c00907","DOIUrl":null,"url":null,"abstract":"<p >Polymers with multiple ε-lysine residues exhibit excellent antibacterial activity and membrane selectivity for bacteria and fungi. This study investigated the optimal number of ε-lysine residues required for antimicrobial activity by comparing peptides with 12, 14, 16, and 18 ε-lysine residues to ε-poly-<span>l</span>-lysine (εPL). Peptides with 16–18 ε-lysine residues showed submicromolar minimum inhibitory concentrations (MICs) against Gram-positive and Gram-negative bacteria while higher MICs for antifungal activity. εPL demonstrated rapid fungicidal activity by disrupting fungal membranes, inhibiting hyphal growth, and eradicating biofilms in vitro. In rabbit models of corneal epithelial injury, εPL did not impede wound healing. Topical or intrastromal εPL significantly reduced fungal burden and disease severity in a rabbit model of <i>Fusarium</i> keratitis. In a mouse model of <i>Candida</i> keratitis, εPL significantly decreased anterior chamber inflammation and fungal burden compared to voriconazole. These promising findings highlight the potential of εPL as an antifungal agent for the management of fungal keratitis.</p>","PeriodicalId":30,"journal":{"name":"Biomacromolecules","volume":"26 10","pages":"6653–6666"},"PeriodicalIF":5.4000,"publicationDate":"2025-09-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biomacromolecules","FirstCategoryId":"92","ListUrlMain":"https://pubs.acs.org/doi/10.1021/acs.biomac.5c00907","RegionNum":2,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Polymers with multiple ε-lysine residues exhibit excellent antibacterial activity and membrane selectivity for bacteria and fungi. This study investigated the optimal number of ε-lysine residues required for antimicrobial activity by comparing peptides with 12, 14, 16, and 18 ε-lysine residues to ε-poly-l-lysine (εPL). Peptides with 16–18 ε-lysine residues showed submicromolar minimum inhibitory concentrations (MICs) against Gram-positive and Gram-negative bacteria while higher MICs for antifungal activity. εPL demonstrated rapid fungicidal activity by disrupting fungal membranes, inhibiting hyphal growth, and eradicating biofilms in vitro. In rabbit models of corneal epithelial injury, εPL did not impede wound healing. Topical or intrastromal εPL significantly reduced fungal burden and disease severity in a rabbit model of Fusarium keratitis. In a mouse model of Candida keratitis, εPL significantly decreased anterior chamber inflammation and fungal burden compared to voriconazole. These promising findings highlight the potential of εPL as an antifungal agent for the management of fungal keratitis.
期刊介绍:
Biomacromolecules is a leading forum for the dissemination of cutting-edge research at the interface of polymer science and biology. Submissions to Biomacromolecules should contain strong elements of innovation in terms of macromolecular design, synthesis and characterization, or in the application of polymer materials to biology and medicine.
Topics covered by Biomacromolecules include, but are not exclusively limited to: sustainable polymers, polymers based on natural and renewable resources, degradable polymers, polymer conjugates, polymeric drugs, polymers in biocatalysis, biomacromolecular assembly, biomimetic polymers, polymer-biomineral hybrids, biomimetic-polymer processing, polymer recycling, bioactive polymer surfaces, original polymer design for biomedical applications such as immunotherapy, drug delivery, gene delivery, antimicrobial applications, diagnostic imaging and biosensing, polymers in tissue engineering and regenerative medicine, polymeric scaffolds and hydrogels for cell culture and delivery.